Source: PRWEB

Press Release: Persomics : Persomics enters into Functional Genomics Screening Agreement with NovellusDx

Persomics, a growing company with innovative solutions that miniaturize, accelerate and increase the scale of phenotypic screening, announced its first custom services agreement with NovellusDx, the leading Precision Cancer Analysis company.(PRWeb October 22, 2015)Read the full story at http://www.prweb.com/releases/2015/10/prweb13034790.htm

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Neil Emans's photo - CEO of Persomics

CEO

Neil Emans

CEO Approval Rating

84/100

Read more